MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹10,233 Cr |
| Mar2024 | ₹5.27 Cr |
| Mar2023 | ₹-740 Cr |
| Mar2022 | ₹605 Cr |
| Mar2021 | ₹-7.81 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,233 Cr | 194,066.22 | |
| Mar2024 | ₹5.27 Cr | Positive | |
| Mar2023 | ₹-740 Cr | Negative | |
| Mar2022 | ₹605 Cr | Positive | |
| Mar2021 | ₹-7.81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹91,160.7 Cr | 0.8% | 7.7% | -2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.8% |
7.7% |
-2.2% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses